More than half of breast cancer patients who sought a second opinion from a multidisciplinary tumor board received a change in their recommended treatment plan, according to a new study from the University of Michigan Comprehensive Cancer Center.
One in five cancer patients in Scotland is still having to wait for treatment longer than the Executive?s own two-month target. But yesterday, health minister Andy Kerr promised improvements and revealed new ways for health boards to meet targets.
?terna Zentaris Inc. (TSX: AEZ; NASDAQ: AEZS) today disclosed additional positive top line Phase 1 results for its cytotoxic conjugate AN-152 in patients with gynaecological and breast cancers. Further data showed the compound?s good safety profile and established the maximum tolerated dose (MTD) at 267 mg/m? which will be the recommended dose for a Phase 2 trial. In addition to good safety data, the trial provided a hint of efficacy as disease stabilization and regression of lesions were observed at the 160 mg/m? and 267 mg/m? dose levels.
A cadre of world-renowned scientists working in the most promising areas of cancer research have come together to work as a team at one institution ? Memorial Health ? to accelerate findings for the prevention and treatment of cancer.
Certain women may miss out on routine tests that screen for early signs of breast cancer. Elderly women, women with publicly funded health insurance and women who don’t go to an obstetrician and gynecologist for routine exams are all less likely than others to get a clinical breast exam and a recommendation for a mammogram.
Cancer researchers have found that a gene that is involved in regulating aging also blocks prostate cancer cell growth. They have shown that the enzyme SIRT1 can block the growth of treatment-resistant prostate cancer cells that overexpress a mutation for the androgen receptor. The scientists hope the newly found connection will aid in better understanding the development of prostate cancer and lead to new drugs against the disease.
Breast cancer sufferers could eventually benefit from high-tuned, tailor-made drug treatments that minimize side effects as a result of a joint initiative between computer scientists in Edinburgh and cellular biologists in Japan.
Mayo Clinic Cancer Center researchers have found that a radical prostatectomy can be a viable option for select octogenarian patients. The findings, which run counter the conventional practice of generally avoiding surgeries for individuals over 80 years old solely based on age, are available today in Urology.
The National University of Singapore has developed a new non-invasive method to detect cancer earlier, the doctors have adopted a new screening technique of shining near-infrared rays on patients’ problem areas, instead of currently using white light endoscopies.
Prime Minister Stephen Harper of Canada unveiled a five-year, $260-million national program for fighting cancer in the country on Friday. Harper announced the establishment of the Canadian Partnership Against Cancer — a not-for-profit corporation that will oversee the five-year initiative.